Fetal obstructive uropathy: patterns of renal pathology.
Fetal obstructive uropathy (FOU) is characterized by obstruction of the urethra, renal anomalies, ureterovesical dilatation, oligohydramnios, cryptorchidism, and abdominal muscle wall changes. The main objective of the present study was to better understand the relationship between FOU and renal pathology using a series of 15 male autopsy cases. A total of 11 cases with patent anus and 4 with imperforate anus were analyzed. Of the first group, most cases showed obstruction at the level of prostatic urethra. Seven cases showed obstruction at the level of the prostatic urethra and histologic study revealed scarring and partial or complete absence of the prostate, while in the remaining four cases the prostate was present. Of the cases with imperforate anus, two showed obstruction at the level of prostatic urethra, one showed posterior urethral valves, and one was obstructed at the proximal urethra. In all cases the kidneys showed mixed (dysplastic and cystic) changes with no significant differences between the two groups. An inverse correlation was observed between degree of renal dysplasia and gestational age, whereas the opposite was true for cystic changes. Distal and collecting tubules were more intensely immunoreactive to the anti-cytokeratin antibody when compared to proximal tubules. Moreover, anti-cytokeratin immunoreactivity was more prominent in tubules displaying cystic dilatation. DNA fragmentation analysis of renal tissue revealed a higher apoptosis of mesenchymal and tubular cells in the FOU cases, compared to gestational aged-matched controls. These results suggest that renal anomalies in FOU might be related to the gestational age at which the injury occurred and to the duration of the obstruction.
Poucell-Hatton
S
S
Department of Pathology, University of California, San Diego-Medical Center, 200 West Harbor View, San Diego, CA 92103-8321, USA.
Huang
M
M
Bannykh
S
S
Benirschke
K
K
Masliah
E
E
D017209:Apoptosis; D053938:DNA Fragmentation; D005333:Fetus / Q000002:abnormalities*; D005865:Gestational Age; D006801:Humans; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D007633:Keratins / Q000032:analysis; D007668:Kidney / Q000002:abnormalities*; D052177:Kidney Diseases, Cystic / Q000196:embryology; D008297:Male; D011467:Prostate / Q000002:abnormalities*; D011535:Prune Belly Syndrome / Q000196:embryology; D014521:Urethra / Q000002:abnormalities* / Q000098:blood supply; D014524:Urethral Obstruction / Q000196:embryology; D014564:Urogenital Abnormalities / Q000196:embryology*
D007633:Keratins